Michael Shetzline: SVP, CMO, Head-Res&Drug at Ironwood Pharmaceuticals Inc, stock sales and holdings

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

To cover taxesOne dollar scale for every month; the tallest bar is labeled

What the filings show, past 12 months. Nothing here rates or predicts.

Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026.
Largest single sale: $59K (15,570 shares) of Ironwood Pharmaceuticals Inc on Feb 23, 2026. Filing
Last sale before this period: Feb 10, 2025.

Every company we track where this person has filed, newest filing first.

Company	Title	First filing	Latest filing
Ironwood Pharmaceuticals Inc (IRWD)	SVP, CMO, Head-Res&Drug	Apr 21, 2020	Mar 12, 2026

The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

Mar 10, 2026, Ironwood Pharmaceuticals Inc: 136,612 shares granted. 1 filing: 1
Feb 24, 2026, Ironwood Pharmaceuticals Inc: sold 17,012 shares for $62K, to cover taxes. 1 filing: 1
Feb 23, 2026, Ironwood Pharmaceuticals Inc: sold 15,570 shares for $59K, to cover taxes. 1 filing: 1

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.